CNBC Fast Money July 11, 2024
Hey, melissa, these results were so much better, and if all went really well melissa, we have 90 of efficacy with this trial and this Covid Vaccine from pfizer. This is a 44,000participant trial. The way they measure efficacy is how many cases of covid they see in the trial they want to see more cases in the placebo arm than the vaccine arm, to show that the vaccine is protective thats what they saw to the opportunity of 90 efficacy. They said they saw no serious safety concerns, and they will proceed to the end of the twomonth safety followup window before they would seek emergency use author...
Source: archive.org